Physicochemical Properties
| Molecular Formula | C10H14N6O4 | 
| Molecular Weight | 282.26 | 
| Exact Mass | 282.107 | 
| CAS # | 2096-10-8 | 
| PubChem CID | 72200 | 
| Appearance | White to off-white solid powder | 
| Density | 2.3±0.1 g/cm3 | 
| Boiling Point | 798.5±70.0 °C at 760 mmHg | 
| Melting Point | 241-243°C (dec.) | 
| Flash Point | 436.7±35.7 °C | 
| Vapour Pressure | 0.0±3.0 mmHg at 25°C | 
| Index of Refraction | 1.986 | 
| LogP | -1.08 | 
| Hydrogen Bond Donor Count | 5 | 
| Hydrogen Bond Acceptor Count | 9 | 
| Rotatable Bond Count | 2 | 
| Heavy Atom Count | 20 | 
| Complexity | 363 | 
| Defined Atom Stereocenter Count | 4 | 
| SMILES | C1=NC2=C(N=C(N=C2N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N)N  | 
                            
| InChi Key | ZDTFMPXQUSBYRL-UUOKFMHZSA-N | 
| InChi Code | InChI=1S/C10H14N6O4/c11-7-4-8(15-10(12)14-7)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H4,11,12,14,15)/t3-,5-,6-,9-/m1/s1 | 
| Chemical Name | (2R,3R,4S,5R)-2-(2,6-diaminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol | 
| HS Tariff Code | 2934.99.9001 | 
| Storage | 
                                     Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. | 
                            
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) | 
Biological Activity
| References | 
                                    
                                         [1]. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500.  | 
                            
| Additional Infomation | 2-Aminoadenosine is a purine nucleoside. | 
Solubility Data
| Solubility (In Vitro) | DMSO : ~100 mg/mL (~354.28 mM) | 
| Solubility (In Vivo) | 
                                    Solubility in Formulation 1:  ≥ 2.5 mg/mL (8.86 mM) (saturation unknown)  in  10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (8.86 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.  (Please use freshly prepared in vivo formulations for optimal results.)  | 
                            
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 3.5428 mL | 17.7142 mL | 35.4283 mL | |
| 5 mM | 0.7086 mL | 3.5428 mL | 7.0857 mL | |
| 10 mM | 0.3543 mL | 1.7714 mL | 3.5428 mL |